We report results of a retrospective review of intra-aortic balloon pump (IABP) use in two Australasian centres and evaluate the effect of final IABP tip position on outcome. Indications for counterpulsation, patient demographics and in-hospital outcomes and complications were retrospectively collected. The chest X-ray reports provided the 'final' position of the IABP tip. The position was defined as acceptable (tip was seen just below the aortic arch, at T2-T5 vertebrae), malpositioned (tip >5 cm below aortic arch or at T5-T6) or severely malpositioned (tip >10 cm below aortic arch or at T7 or below). Major complications were considered a composite of death secondary to IABP, major limb ischaemia, major IABP malfunction, balloon rupture or haemorrhage, severe renal dysfunction (rise in creatinine >200 µmol/l), stroke and mesenteric ischaemia. Six hundred and forty-five cases were reviewed. The overall major complication rate was 26.2% and 24.3%. Severe renal impairment was the most common complication (16.6%), and second, severe catheter dysfunction (5.4%). Final IABP position was acceptable in 39.9%, malpositioned in 11.1%, severely malpositioned in 6.7% and unavailable for 42.4%. Logistic regression analysis showed IABP tip malposition (compared with satisfactory position odds ratio=3.9 [95% confidence interval=2.0-7.6, P <0.001] and severely malpositioned odds ratio=13.0 [95% confidence interval=5.3-31.7, P <0.001]) were associated with major complications more than the presence of shock (odds ratio=3.8, confidence interval 2.1-6.8 P <0.001). The acceptance of a less than ideal final position was highly predictive of morbidity directly related to IABP device therapy.
The intra-aortic balloon pump (IABP) is currently the most widely used circulatory assist device for the treatment of cardiogenic shock, a condition which remains associated with high mortality rates 1, 2 . The potential for benefit of counterpulsation in the setting of cardiogenic shock has been demonstrated previously [3] [4] [5] . A recent randomised controlled trial has questioned the benefit of IABP use in the setting of acute myocardial infarction (AMI) treated with primary percutaneous intervention (PCI) as opposed to thrombolytics 6 . It is of interest to note however, that when IABPs are compared to more aggressive forms of mechanical support such as percutaneous left ventricular assist devices, there is still no firm evidence of improved survival rates despite the increased cost and complexity of treatment with percutaneous left ventricular assist devices 7, 8 .
For the last five decades, the indications for IABP use have expanded as confidence in its safety has increased. There has been a move from reserving IABP use for patients in extremis towards use as a prophylactic measure in both high-risk PCI and high-risk cardiac surgery [9] [10] [11] [12] [13] . However, the potential for complications still exists despite advances in catheter design and increasing sophistication of consoles.
Current theories regarding counterpulsation-related complications are often based on results from the Benchmark Registry, a large, highly regarded, multicentre registry 14 . This registry has identified the presence of peripheral vascular disease, female sex, body surface area <1.65m 2 and age >75 years as significant, independent predictors of major complications following IABP therapy. Subsequent studies have confirmed these findings and, in addition, identified reduced left ventricular ejection fraction as an additional risk factor [15] [16] [17] [18] .
In this study, we elected to look at the association of final IABP tip position with the occurrence of major complications including renal dysfunction. The possibility of IABP tip migration exists in practice but the potential may be underestimated. There is currently no standardised protocol suggesting the frequency with which the IABP tip position should be reassessed post placement.
Methods
Patients who received IABP device therapy from 1998 to 2008 were identified from records held by the perfusionists and cardiology technicians of Christchurch and Dunedin Hospitals and cross-referenced with the internal coding system at each hospital. Indications for counterpulsation, patient demographics, clinical characteristics, in-hospital outcomes and complications were documented retrospectively from the individual patient medical records by a single investigator. An ethics application was made to the Upper South B Regional Ethics Committee, which confirmed that no formal ethics approval was required for this retrospective review.
Christchurch and Dunedin Hospitals are tertiary referral centres and teaching hospitals that provide on-site cardiac surgery. All devices in Christchurch and Dunedin used during that period were Datascope (Datascope Corp., Maquet Getinge Group, Fairfield, NJ, USA), with eight French calibre catheters.
Major complications relating to IABP were divided into two categories. Major complications group 1 was as reported in the Benchmark Registry so that direct comparisons could be made. This category was a composite of death secondary to counterpulsation, major limb ischaemia (defined as requiring premature discontinuation of counterpulsation or the need for surgical intervention in the form of embolectomy or amputation), balloon malfunction requiring premature removal, balloon rupture and haemorrhage secondary to the IABP insertion requiring blood transfusion. Major complication group 2 was a composite endpoint of major complication group 1 and, in addition, severe renal dysfunction (defined as a rise in plasma creatinine of >200 μmol/l from baseline), stroke and either proven or suspected mesenteric ischaemia.
The chest radiograph reports provided the 'final' position of the radio-opaque tip. The position was defined as acceptable, malpositioned, severely malpositioned or unavailable. An acceptable IABP position was recorded when the tip was seen just below the aortic arch, at T2-T5 if referenced according to the thoracic vertebral bodies, or at the bifurcation of the carina. A malpositioned IABP was defined as the tip being greater than 5 cm below aortic arch or at T5-T6. A severely malpositioned IABP was defined as the tip being greater than 10 cm below aortic arch or referenced at T7 or below ( Figure 1 ). If the IABP tip was repositioned from being malpositioned or severely malpositioned to an acceptable position within six hours, the position was taken as acceptable. The IABP position was recorded as unavailable when the tip position was not mentioned on the chest radiograph report or in patients for whom no chest radiograph was taken after IABP placement. The chest X-rays were reported by experienced consultant radiologists. To ensure the accuracy of the radiologist's reports, all digitally stored chest radiographs were reviewed.
Shock, usually cardiogenic, at the time of IABP insertion was defined as a clearly documented sustained systolic blood pressure below 80 mmHg. A record of inotrope and/or vasopressor use was noted.
Statistical analysis
The relationship between major complications and clinical setting (cardiology, preoperative, intra-or postoperative), method of IABP insertion (fluoroscopic guidance, insertion doctor), duration of use, presence of shock, mortality and hospital where IABP insertion was performed were analysed using chi-square and Fisher exact tests. Associations between major complications and age and risk scores were analysed with analysis of variance.
Factors significantly associated with major complications were included in a multivariate, stepwise forward, conditional logistic regression. The factors interrogated included Figure 1 : A=Acceptable position-just below the aortic arch, at T2-T5, or at bifurcation of the trachea (n=251). B=Malpositioned-at T5-T6, greater than 5 cm below the aortic arch (n=72). C=Severely malpositioned-at T7 or below, greater than 10 cm below aortic arch (n=36). the presence of peripheral vascular disease, female sex, age, hypertension and ejection fraction <35%. These factors have previously been identified as predictors of complication [14] [15] [16] [17] [18] . In addition, the presence of shock at the time of insertion, the clinical setting in which the IABP was placed, whether fluoroscopy was used during the insertion, the duration of counterpulsation use, and whether the final chest X-ray position was acceptable were included.
Once the significance of each factor was determined with this model, the odds ratios (OR) and 95% confidence intervals (CI) were determined by an enter or base model. The IABP tip position groups were entered as four separate groups consisting of acceptable, unavailable, malpositioned or severely malpositioned.
ORs reported for malpositioned IABPs are relative to the chance of a complication if the chest radiograph showed an acceptable position. All statistical analyses were performed using SPSS, version 19 (IBM, Armonk, NY, USA), and a P-value of <0.05 was taken to indicate statistical significance.
Results

Patient characteristics
Six hundred and seventy-three patients who received IABP device therapy were identified and medical records were available for 645 (95.8%). The mean age of patients (n=645) was 66 years (standard deviation ± 12 years) and 432 (66.9%) were male. Nearly a quarter of patients, 135 (20.9%), had diabetes, 400 (62.0%) were hypertensive, 432 (66.9%) were hyperlipidaemic, 122 (18.9%) were current smokers and 77 (11.9%) had a documented history of peripheral vascular disease. Of the surgical group, 19 (4.5%) were also on extracorporeal membrane oxygenation and 7 (1.2%) were supported with right ventricular assist devices. More than half, 342 (53.0%), of the patients in whom counterpulsation was utilised were in shock at the time of IABP insertion, with 279 (81.5%) of this group requiring inotropic and/or vasopressor support.
IABP use in Dunedin and Christchurch
The characteristics of IABP use and the rate of major complications group 1 (as listed in the Benchmark Registry) and major complications group 2 are reported separately for Christchurch and Dunedin Hospitals in Table 1 . In Dunedin, the majority, 149/153 (97.8%), of the cardiac surgery was performed on bypass or 'on pump' and in Christchurch the majority, 173/257 (67.3%), of coronary artery grafting was 'off pump'. Of the 645 IABPs placed, 242 (37.5%) were placed in Dunedin and 403 (62.4%) were placed in Christchurch ( Table 1 ).
The indications for use were as follows: preoperative highrisk cardiac surgery 233 (36.1%), AMI-the majority of whom were shocked and undergoing primary PCI-131 (20.3%), failure to wean from cardiopulmonary bypass 116 (17.9%), intraoperative instability during 'off pump' cardiac surgery 42 (6.5%), postoperative cardiovascular instability 34 (5.3%), AMI complicated by acute severe mitral regurgitation or ventricular septal defect 26 (4.2%), post arrest with continuing ventricular arrhythmias 26 (4.0%), emergent need for elective PCI 15 (2.3%), AMI with refractory angina 9 (1.3%), left ventricular failure 5 (0.8%), myocarditis 4 (0.6%) and prophylactic use in high-risk elective PCI 4 (0.6%). 
IABP tip placement
Analysis of chest radiograph reports showed that the final IABP position was acceptable in 251 (39.9%), malpositioned in 72 (11.1%) patients and severely malpositioned in 43 (6.7%) patients. Chest X-ray data was unavailable for 274 (42.4%). Of these 274 cases, 99 (35.8%) had support for <2 or 2 to 12 hours. Twenty-five out of forty-one (60.9%) of the <2 hour group and 24/58 (41.3%) of the 2 to 12 hour group died. Of the patients in the unavailable group that had support for >48 hours, 108/119 (90.8%) had the devices placed with fluoroscopic guidance.
To validate the use of chest radiograph reports in the analysis, all digitally stored X-rays were assessed. Out of the 645 cases, 136 (21.1%) had digitally stored X-rays that could be re-evaluated. All but one correlated with the report categories used (category changed from unavailable to acceptable).
Estimation of the degree of migration
In an attempt to estimate the degree of migration, patients who received preoperative counterpulsation in Christchurch between 2004 and 2008 were identified. Thirty-eight of the 101 patients had recorded cine images in the catheterisation laboratory. In 35 cases of the 38, the IABP position before and after surgery was successfully referenced according to the distance between the radio-opaque tip to the aortic arch by a consultant thoracic radiologist.
The preoperative cine imaging showed that 34/35 (97.1%) were in an acceptable position with the average distance being 24.7 mm from the arch. One out of 35 was in an unacceptable position at 62 mm. The postoperative images showed that 18/35 (51.4%) were still in an acceptable position with 16 (45.7%) malpositioned (average distance from arch being 69.7 mm) and 1 (2.9%) severely malpositioned at 140 mm, migrating down 78 mm. Therefore, in the 35 that could be tracked accurately before and after surgery, the average migration distance was 26.4 mm.
Major complications
The individual complication rates for the entire group were as follows: severe renal impairment 107 (16.6%), severe catheter dysfunction 35 (5.4%), severe bleeding 19 (2.9%), lower limb ischaemia 17 (2.6%), stroke 15 (2.3%), balloon rupture or leak 15 (2.3%), death related to counterpulsation 8 (1.2%), mesenteric ischaemia 7 (1.1%), vessel perforation 3 (0.5%) and entrapment 1 (0.2%).
Although the major complications group 1 rate in both New Zealand centres are higher than the estimate from the Benchmark Registry as published in 2001 (Table 1) , subsequent frequencies from the Benchmark Registry are higher at 6.2% 14, 19 . This may reflect a more real-life estimate as larger numbers of centres join the registry.
Univariate analysis showed a striking stepwise increase in major complication group 2 with an increasing degree of displacement (Table 2 ). There was a higher incidence of major complications if fluoroscopy was not or could not be used for both major complications group 1 (without fluoroscopy: 28/193 patients (14.5%), with fluoroscopy: 27/452 patients (6.0%), P <0.001) and major complications group 2 (without fluoroscopy: 77/193 patients (39.9%), with fluoroscopy: 94/452 patients (20.6%), P <0.001).
Logistic regression analysis showed the final IABP position was the strongest independent predictor of major complications group 2 (including renal dysfunction, mesenteric ischaemia and strokes). The risk of developing major complication group 2 if the IABP was malpositioned was 3.9-fold (CI=2.0 to 7.6, P <0.001), and 13.0-fold (95% CI=5.3 to 31.7, P <0.001) if the IABP was severely malpositioned. For those in whom Major complication group 1 is a composite of death secondary to counterpulsation, major limb ischaemia, balloon malfunction requiring premature removal, balloon rupture and haemorrhage secondary to the IABP insertion requiring blood transfusion. Major complication group 2 is a composite of group 1 plus severe renal dysfunction, mesenteric ischaemia and stroke. IABP=intra-aortic balloon pump. Reference category for chest X-ray position was 'acceptable'. Reference category for group setting was preoperative placement. Major complication group 2 is a composite of death secondary to counterpulsation, major limb ischaemia, balloon malfunction requiring premature removal, balloon rupture, haemorrhage secondary to the IABP insertion requiring blood transfusion, severe renal dysfunction, mesenteric ischaemia and stroke. IABP=intra-aortic balloon pump. Reference category for chest X-ray position was 'acceptable'. Reference category for group setting was preoperative placement. the final position was unavailable, the chance of developing a major complication group 2 was 1.4 (CI=0.8 to 2.3, P=0.188). In addition, shock was also independently prognostic of major complications group 2 (OR=3.8, CI=2.1 to 6.8 P <0.001). Older age, a history of diabetes and the setting of which the IABP was placed (cardiology or surgical) were not independently associated with major complications in group 2 (Figure 2 and Table 3 ). Further logistic regression analysis of the two most common major complications making the composite major complication group 2 were also examined, namely severe renal impairment-a creatinine rise of >200 μmol/l ( Figure 3 and Table 4 ) and severe catheter malfunction ( Figure 4 and Table 5 ) .
Discussion
Our review of counterpulsation therapy in two centres in New Zealand showed that an unsatisfactory final IABP tip position was the main factor associated with subsequent development of major complications. This is the first study to investigate whether the final position of the IABP tip is associated with increased morbidity. When looking at all major complications, including severe renal dysfunction, stroke and mesenteric ischaemia, the risk increased in a stepwise manner with increasingly poor tip placement from 3.9 to 13-fold. When looked at separately, the two most commonly occurring major complications-severe renal dysfunction and catheter dysfunction-also increased in a stepwise fashion. Previously, there have been case reports of misplaced catheters causing impaired organ perfusion but the risk has not been quantitated 20, 21 .
With regards to increased incidence of severe renal dysfunction, IABP tip position remained the most significant risk factor in this group. This may reflect impaired augmentation of cardiac output with malpositioned devices or direct impairment of blood-flow distally, despite the deflation during systole. Similarly, the increased incidence of mesenteric ischaemia is intuitive and biologically plausible. Of the patients suffering from strokes however, review of case files commonly demonstrated an alternative cause such as preexisting severe carotid artery disease, mural thrombus or watershed type infarction secondary to periods of extreme hypotension. Interestingly, IABP tip position was not associated with increased mortality in this group.
The failure to adjust the misplaced devices possibly reflects the perception that absolute detail to positioning is not required or that there may be increased risk of infection if the IABP is advanced. Not uncommonly, physicians feel reassured by other parameters such as the absence of acidosis or adequate urine output. Some would argue that since the IABP is deflated during systole, absolute attention to tip position is not required. Our data would argue to the contrary. This study also suggests that potential for tip migration may be more common than appreciated. 
Odds Ratio
Limitations
Retrospective determination of factors associated with an increased incidence of complications does not prove cause and effect. With severe renal dysfunction for example, some patients had multiple factors for developing this complication including pre-renal factors such as hypoperfusion, exposure to nephrotoxic agents such as contrast agents or undergoing cardiopulmonary bypass. However, the increase in the risk of major complications with worse catheter misplacement follows a clear stepwise pattern, strongly suggesting cause and effect.
The final position of the IABP tip was not available in over 40% of patients. For those who received perioperative counterpulsation, given the policy in both hospitals of obtaining a chest radiograph as routine in intensive care admissions, it may be that the team had assessed IABP tip position despite this not being included in the radiographer's report. It is also possible that tip position was assessed by other means such as transoesophageal echocardiography. Although the number with tip position being unavailable by radiograph reports remains a potential limitation of this retrospective study, the ORs are statistically robust. In addition, the IABP tip position was entered as four separate groups into the logistic regression analysis. The risk estimates did not change appreciably when the unavailable group was excluded from the analysis. Finally, the consequences of malpositioned IABPs cannot be ethically determined in a prospective study.
Conclusion
The acceptance of a less than ideal final position was highly predictive of morbidity directly related to IABP device therapy. The results would favour the initial placement of these devices under direct imaging and highlight the importance of monitoring final device position by chest radiograph or by other established means such as transoesophageal echocardiography. Particular care should be exercised in fixing the device in optimal position from the outset of its deployment as the potential for IABP tip migration may be underestimated.
Our findings suggest routine confirmation and documentation of final IABP tip placement should be mandatory with IABP use, as this is likely to lead to improved complication rates.
